Cargando…
Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small-cell lung cancer: the PUMA trial
BACKGROUND: Patients with locally-advanced non-small-cell lung cancer (LA-NSCLC) are often ineligible for surgery, so that definitive chemoradiotherapy (CRT) represents the treatment of choice. Nevertheless, long-term tumor control is often not achieved. Intensification of radiotherapy (RT) to impro...
Autores principales: | Regnery, Sebastian, de Colle, Chiara, Eze, Chukwuka, Corradini, Stefanie, Thieke, Christian, Sedlaczek, Oliver, Schlemmer, Heinz-Peter, Dinkel, Julien, Seith, Ferdinand, Kopp-Schneider, Annette, Gillmann, Clarissa, Renkamp, C. Katharina, Landry, Guillaume, Thorwarth, Daniela, Zips, Daniel, Belka, Claus, Jäkel, Oliver, Debus, Jürgen, Hörner-Rieber, Juliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161406/ https://www.ncbi.nlm.nih.gov/pubmed/37143154 http://dx.doi.org/10.1186/s13014-023-02258-9 |
Ejemplares similares
-
Correction : Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small cell lung cancer: the PUMA trial
por: Regnery, Sebastian, et al.
Publicado: (2023) -
A practical implementation of risk management for the clinical introduction of online adaptive Magnetic Resonance-guided radiotherapy
por: Klüter, Sebastian, et al.
Publicado: (2021) -
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study
por: Klaar, Rabea, et al.
Publicado: (2023) -
Quality assurance for on‐table adaptive magnetic resonance guided radiation therapy: A software tool to complement secondary dose calculation and failure modes discovered in clinical routine
por: Rippke, Carolin, et al.
Publicado: (2022) -
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
por: Hoegen, P., et al.
Publicado: (2022)